Geode Capital Management LLC Acquires 476,365 Shares of Sotera Health Company $SHC

Geode Capital Management LLC boosted its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 13.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,931,834 shares of the company’s stock after acquiring an additional 476,365 shares during the period. Geode Capital Management LLC’s holdings in Sotera Health were worth $69,372,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Capricorn Fund Managers Ltd bought a new stake in shares of Sotera Health in the 4th quarter valued at about $7,936,000. Nordea Investment Management AB bought a new stake in shares of Sotera Health in the 4th quarter valued at about $1,908,000. Exchange Traded Concepts LLC bought a new stake in shares of Sotera Health in the 4th quarter valued at about $7,739,000. Retirement Systems of Alabama boosted its holdings in shares of Sotera Health by 16.9% in the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock valued at $4,391,000 after buying an additional 35,974 shares in the last quarter. Finally, Hudson Bay Capital Management LP bought a new stake in shares of Sotera Health in the 3rd quarter valued at about $3,932,000. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Price Performance

Shares of SHC opened at $15.86 on Tuesday. The firm has a market capitalization of $4.52 billion, a PE ratio of 38.68 and a beta of 1.79. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. Sotera Health Company has a 1-year low of $10.80 and a 1-year high of $19.85. The company’s fifty day moving average price is $15.41 and its 200-day moving average price is $16.37.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities research analysts predict that Sotera Health Company will post 0.86 EPS for the current year.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 15.36% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Weiss Ratings cut shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a report on Friday. They issued a “buy” rating and a $20.00 price target on the stock. Citigroup raised their price target on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Barclays lowered their price target on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Finally, Piper Sandler restated an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.29.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.